<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H0F8587251CCA46C5B6CCAB0721E4D7C2" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 1627 IH: Telehealth Response for E-prescribing Addiction Therapy Services Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-02-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1627</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250226">February 26, 2025</action-date><action-desc><sponsor name-id="N000188">Mr. Norcross</sponsor> (for himself and <cosponsor name-id="F000466">Mr. Fitzpatrick</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to allow for the use of telehealth in substance use disorder treatment, and for other purposes.</official-title></form><legis-body id="HE13C1A546A9B4C8B8B8D46A8D1A5684B" style="OLC"><section section-type="section-one" id="H792982F6F8C242EC918101C69815E703"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Telehealth Response for E-prescribing Addiction Therapy Services Act</short-title></quote> or the <quote><short-title>TREATS Act</short-title></quote>.</text></section><section id="H9C2264843BA241B88CCA8FC9EFAAD067"><enum>2.</enum><header>Telehealth for substance use disorder treatment</header><text display-inline="no-display-inline">Section 309(e)(2) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/829">21 U.S.C. 829(e)(2)</external-xref>) is amended—</text><paragraph id="H0CF1E665943C4DFDB7808A9AF89326A4"><enum>(1)</enum><text>in subparagraph (A)(i)—</text><subparagraph commented="no" display-inline="no-display-inline" id="H5814936A897F43BB912512C127E7D2E5"><enum>(A)</enum><text display-inline="yes-display-inline">by striking <quote>at least 1 in-person medical evaluation</quote> and inserting the following: </text><quoted-block style="OLC" display-inline="yes-display-inline" id="HCF00AEDB8F1D498FA5C8397ED4F6CF82"><text>at least—</text><subclause id="H9E7F2B7623FC49ADA4E61BC350EAD595"><enum>(I)</enum><text display-inline="yes-display-inline">1 in-person medical evaluation</text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="H05A72FDE59A44493B9CB0DD938B351FD"><enum>(B)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="HD6C36B6A31CA4D5CB2CB6AEFE943C869"><subclause commented="no" display-inline="no-display-inline" id="HAFE05650BB704C8ABBCB538718852BC8"><enum>(II)</enum><text display-inline="yes-display-inline">for purposes of prescribing a controlled substance in schedule III, IV, or V that has been approved by the Food and Drug Administration for the treatment of a substance use disorder, 1 telehealth evaluation of the patient; or </text></subclause><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H1C47807550BF48F2A3A6371EA3D5A3AF"><enum>(2)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" display-inline="no-display-inline" id="H469B7482595B4F758A63F2AFEDC4EA03"><subparagraph id="H2049313A1432421692A160B2F4F15B0F"><enum>(D)</enum><text display-inline="yes-display-inline">The term <term>telehealth evaluation</term> means a medical evaluation that is conducted in accordance with applicable Federal and State laws by a practitioner (other than a pharmacist) who is at a location remote from the patient and is communicating with the patient, or a practitioner who is treating the patient, using a telecommunications system referred to in section 1834(m) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395m">42 U.S.C. 1395m(m)</external-xref>) that includes audio-only or audio and video equipment permitting two-way, real-time interactive communication between the distant site practitioner and the patient, or the practitioner who is treating the patient.</text></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section></legis-body></bill> 

